Ilios Therapeutics
PrivateLast Round
Seed
Sep 5, 2023
Company Overview
Ilios Therapeutics is a biotechnology company that develops multi-functional, brain-penetrant small molecules to treat neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ilios Therapeutics Comparables
Compare Ilios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muna Therapeutics | 79% | |
| Arkuda Therapeutics | 77% | |
| Eikonizo Therapeutics | 77% |
Ilios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2023 | ||||
| Accelerator | Jul 11, 2022 | ||||
| Pre Seed | Apr 1, 2022 |
Ilios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Launch Lab | Pre Seed |
| Harvard Innovation Labs | Pre Seed |
| Club degli Investitori | Seed |
| Catalisi | Seed |
| MassChallenge Israel | Accelerator, Pre Seed |
| InnoSpark Ventures | Seed |
| Exor Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2023
Seed round raised with participation from Exor Ventures and 3LB Seed Capital.
- Jul 11, 2022
Received funding from MassChallenge Israel.
Ilios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ilios Therapeutics's valuation, stock price, and market status.
Is Ilios Therapeutics a public or private company?
Ilios Therapeutics is a private company.
What is the current stock price of Ilios Therapeutics?
Ilios Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Ilios Therapeutics worth (valuation)?
Valuation information for Ilios Therapeutics is not publicly available.
Can I buy Ilios Therapeutics stock?
Ilios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ilios Therapeutics's last funding round?
Ilios Therapeutics's most recent funding round was Seed on September 5, 2023.
Who are the main investors in Ilios Therapeutics?
Key investors in Ilios Therapeutics include Harvard Innovation Launch Lab, Harvard Innovation Labs, Club degli Investitori, Catalisi, MassChallenge.
Will Ilios Therapeutics IPO soon?
No public IPO plans have been announced for Ilios Therapeutics.
How can I track Ilios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ilios Therapeutics's secondary market activity and sign up for updates.